Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 251 results for "amgen rank"

Key Takeaways from Amgen's (AMGN) Q2 Earnings Report

These 7 were hand-picked from the list of 220 Zacks Rank #1 Strong Buys with earnings estimate revisions that are sweeping upward. Their stock prices are expected to rise sooner than the others. Today, this Special Report will be available to ... Zacks.com, 1 month ago

1 images for "amgen rank"

Providence Business News, 1 month ago

A Post-Earnings Review Of Amgen, With Discussion Of The Repatha Launch

Aug. 3, 2015 11:40 AM ET | About: Amgen Inc. (AMGN), Includes: AZN, BIIB, GSK, IBB, NVS, PFE, REGN, RHHBY, SNY, VRTX by: DoctoRx Summary Amgen, a famous mega-cap biotech, has reported a beat-and-raise quarter. The stock has surged to an ...
 Seeking Alpha1 month ago Amgen (AMGN) Trading Near $166.36 Resistance Level  TradingCharts.com1 month ago Amgen (AMGN) Showing Bullish Technicals With Support At $159.56  Individual.com1 month ago

Potential Amgen (AMGN) Trade Has 1.80% Downside Protection

For a hedged play on Amgen Inc ( AMGN ) MarketIntelligenceCenter.comaEUR(TM)s algorithms selected the Sep. '15 $170.00 covered call for a net debit in the $160.76 area. That is also the break-even stock price for the covered call. This trade will ...
 TradingCharts.com1 month ago Potential Amgen (AMGN) Trade Has 3.37% Downside Protection  Individual.com1 month ago Potential Amgen (AMGN) Trade Has 2.05% Downside Protection  Individual.com2 months ago

Regeneron, Amgen Downgraded As Biotech Seen Slowing

U BS downgraded Regeneron (NASDAQ: REGN ) and Amgen (NASDAQ: AMGN ) and adjusted the price targets on several other biotech stocks Thursday on the grounds that the sector may be in for a slow patch. "Although we still think that biotech will ...
 Investor's Business Daily1 month ago

Amgen a Top 25 Dividend Giant With 2.04% Yield (AMGN)

Follow Comments Following Comments Unfollow Comments Amgen Inc (NASD: AMGN) has been named as a Top 25 Dividend Giant by ETF Channel, with a staggering $5.53B worth of stock held by ETFs, and above-average DividendRank statistics including a ...
 Forbes.com1 month ago

Amgen Beats on Q2 Earnings & Revenues, Raises Outlook

Biotech major, Amgen ( AMGN - Analyst Report ), reported second quarter 2015 earnings of $2.57 per share, soaring above the Zacks Consensus Estimate of $2.43 and the year-ago earnings of $2.37. Earnings were driven by higher revenues and lower ...
 Zacks.com1 month ago Will Amgen (AMGN) Keep the Earnings Streak Alive in 2Q?  Zacks.com1 month ago

FDA approves carfilzomib in combination with lenalidomide and dexamethasone for relapsed multiple myeloma

, the U. S. Food and Drug Administration approved carfilzomib (Kyprolis, Onyx Pharmaceuticals, Inc., an Amgen subsidiary) in combination with lenalidomide and dexamethasone for the treatment of patients with relapsed multiple myeloma who have ...
 Ecancer Medicalscience1 month ago Amgen Reports Positive Data on Leukemia Drug Blincyto  Zacks.com1 month ago
[x]  

Amgen's Repatha Gains EU Nod; First PCSK9 Drug Approved

The first PCSK9 inhibitor has finally gained approval in the EU with the European Commission giving the nod to Amgen Inc. 's ( AMGN - Analyst Report ) Repatha (evolocumab). Although the EU approval was largely expected considering the Committee ...
 Zacks.com1 month ago
[x]  
Ireland Business World

Amgen Foundation has invested almost €600,000 in science education in Ireland

It is estimated that over 15,000 students in Ireland will benefit from Amgen foundation science education investments during the coming academic year. The company who opened a new $300 million facility in Dublin yesterday claimed that more ...
 Ireland Business World1 week ago

Shares of Emergent Biosolutions Rank the Lowest in Terms of Projected Earnings Growth in the Biotechnology Industry (EBS, UTHR, ALXN, AMGN, REGN)

Written on Thu, 07/16/2015 - 4:41am By Amy Schwartz Below are the three companies in the Biotechnology industry with the lowest projected earnings growth. The growth of earnings per share (current fiscal year estimated vs. last year actual) ...
 Comtex SmarTrend1 month ago Lowest Future Earnings Growth in the Biotechnology Industry Detected in Shares of Gilead Sciences (GILD, AMGN, BIIB, MYGN, REGN)  Comtex SmarTrend1 month ago Genomic Health has the Lowest Sales Growth in the Biotechnology Industry (GHDX, ALXN, PDLI, AMGN, UTHR)  Comtex SmarTrend1 month ago Top 5 Companies in the Biotechnology Industry With the Highest PEG Ratio (CPHD, REGN, AMGN, ACOR, LGND)  Comtex SmarTrend1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less